<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00122187</url>
  </required_header>
  <id_info>
    <org_study_id>CRT 02-059</org_study_id>
    <nct_id>NCT00122187</nct_id>
  </id_info>
  <brief_title>Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention</brief_title>
  <official_title>Translation of Colorectal Cancer Screening Guidelines: A System Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United
      States. Results from randomized clinical trials and intervention studies have suggested that
      implementation of a CRC screening program for men and women over age 50 results in reduced
      CRC mortality. However, for this reduction to be fully realized, it is imperative that all
      positive screening tests are followed by complete diagnostic evaluation (CDE). Numerous
      intervention programs have been used to improve initial CRC screening rates, but data
      indicate that outside the research setting, less than half of patients with a positive fecal
      occult blood test (FOBT) screening result undergo CDE. To enhance the translation of this
      best practice recommendation to clinical practice, the investigators propose to implement an
      electronic event notification intervention (CRC-ENS) directed at making physician and system
      level changes to increase the proportion of patients with an abnormal FOBT that undergo CDE.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives: 1.To implement an electronic CRC screening event notification system intervention
      to improve complete evaluation of patients with a positive FOBT at four of eight VAMCs
      randomized to this intervention vs usual care.

      2.To conduct a qualitative evaluation to identify implementation barriers and facilitators,
      and to guide modifications of the CRC-ENS. 3.To conduct an outcome evaluation to determine
      the effectiveness of the intervention to:

      a. increase the proportion of patients with a positive FOBT receiving CDE. b. reduce the
      time-lag between notification of a positive FOBT result and scheduling of a follow-up
      endoscopic procedure. 4. To improve patient compliance with follow-up recommendations through
      combined scheduling.

      Methods: The CRC-ENS intervention employs a relatively simple alteration to the current
      electronic mechanism for notifying the primary care provider (PCP) of when a positive FOBT is
      recorded. With the CRC-ENS, this notification will be forwarded to the gastroenterology (GI)
      clinic as well as the PCP. This notification at the GI clinic will set off a cascade of
      events that would normally only be triggered by a consult request from the PCP. In this
      translation study, eight participating VHA sites will be randomly assigned to either the
      CRC-ENS intervention or usual care group. The proposed project will take two years to
      complete. During the first project year, the participating sites will be recruited and
      randomized. Pre-intervention change of awareness strategies will be initiated at all
      intervention sites. The CRC-ENS intervention will be implemented in the second project year,
      and formative evaluation (including two sets of focus groups) will be carried out throughout
      the intervention period. Post-intervention data collection, outcome evaluation and
      dissemination of results will be carried out in months 18-24.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of Patients Receiving GI Consult for FOBT+ Results</measure>
    <time_frame>6 months</time_frame>
    <description>Percent of patients receiving GI consult within 30, 90, and 180 days of FOBT+ results</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent of Patients Receiving GI Consult Plus Anatomic Workup for FOBT+ Results</measure>
    <time_frame>6 months</time_frame>
    <description>Percent of patients receiving GI consult plus anatomic workup within 30, 90, and 180 days of FOBT+ results</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Electronic Consult System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A new consult system designed to automatically send a gastroenterology consult request for patients with positive fecal occult blood testing (FOBT+) results</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The usual and customary procedures for addressing FOBT+ results: primary care physicians continued to be responsible for follow up of FOBT+ results.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electronic Consult System</intervention_name>
    <description>Consult system is an event notification system programmed to function within the VA electronic medical record system.</description>
    <arm_group_label>Electronic Consult System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - VA Medical Centers with either CORI (Clinical Outcomes Research Initiative) or electronic
        notes/descriptions documenting GI endoscopic procedures

        Exclusion Criteria:

        - VA Medical Centers without electronic GI procedure documentation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linda L. Humphrey, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Portland Health Care System, Portland, OR</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Phoenix VA Health Care System, Phoenix, AZ</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Arizona VA Health Care System</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85723</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Eastern Colorado Health Care System, Denver, CO</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Overton Brooks VA Medical Center</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101-4295</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minneapolis</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Durham VA Medical Center, Durham, NC</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Portland Health Care System, Portland, OR</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tennessee Valley Healthcare System Nashville Campus, Nashville, TN</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212-2637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical &amp; Regional Office Center, White River</name>
      <address>
        <city>White River Junction</city>
        <state>Vermont</state>
        <zip>05009-0001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Tsai TT, Nallamothu BK, Prasad A, Saint S, Bates ER. Clinical problem-solving. A change of heart. N Engl J Med. 2009 Sep 3;361(10):1010-6. doi: 10.1056/NEJMcps0903023.</citation>
    <PMID>19726776</PMID>
  </results_reference>
  <results_reference>
    <citation>Messersmith WA, Ahnen DJ. Targeting EGFR in colorectal cancer. N Engl J Med. 2008 Oct 23;359(17):1834-6. doi: 10.1056/NEJMe0806778.</citation>
    <PMID>18946069</PMID>
  </results_reference>
  <results_reference>
    <citation>Humphrey LL, Shannon J, Partin MR, O'Malley J, Chen Z, Helfand M. Improving the follow-up of positive hemoccult screening tests: an electronic intervention. J Gen Intern Med. 2011 Jul;26(7):691-7. doi: 10.1007/s11606-011-1639-3. Epub 2011 Feb 15.</citation>
    <PMID>21327529</PMID>
  </results_reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2005</study_first_submitted>
  <study_first_submitted_qc>July 18, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2005</study_first_posted>
  <results_first_submitted>December 5, 2013</results_first_submitted>
  <results_first_submitted_qc>December 5, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 27, 2014</results_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cancer</keyword>
  <keyword>colonoscopy</keyword>
  <keyword>mass screening</keyword>
  <keyword>colorectal cancer</keyword>
  <keyword>colorectal carcinoma</keyword>
  <keyword>reminder systems</keyword>
  <keyword>rectal cancers</keyword>
  <keyword>colorectal tumor</keyword>
  <keyword>guidelines</keyword>
  <keyword>CRC secondary prevention</keyword>
  <keyword>colorectal neoplasms</keyword>
  <keyword>colonic neoplasms</keyword>
  <keyword>colonic diseases</keyword>
  <keyword>hemoccult testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>We recruited 8 Veterans Affairs medical centers (VAMCs) to be involved with this trial evaluating a new method of processing positive colorectal cancer screening tests compared with usual care. 4 VAMCs (2 control and 2 intervention sites) dropped out of the study and 4 completed it.</recruitment_details>
      <pre_assignment_details>Participating VAMCs were chosen that had electronic registries for gastroenterology (GI) endoscopic procedures available.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Electronic Consult System</title>
          <description>A new consult system designed to automatically send a gastroenterology consult request for patients with positive fecal occult blood testing (FOBT+) results</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>The usual and customary procedures for addressing FOBT+ results: primary care physicians continued to be responsible for follow up of FOBT+ results.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Matched by Colonoscopy Volume</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Randomized to Intervention or Usual Care</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Intervention Implemented</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Post-intervention Data Collection</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrew because of resource limitations</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The population is the number of VAMCs that enrolled in the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Electronic Consult System</title>
          <description>A new consult system designed to automatically send a gastroenterology consult request for patients with positive fecal occult blood testing (FOBT+) results</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>The usual and customary procedures for addressing FOBT+ results: primary care physicians continued to be responsible for follow up of FOBT+ results.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="8"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <description>Participants in this study were VAMCs rather than human subjects. Age of participants was not collected because it was not applicable.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Not collected</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <description>Participants in this study were VAMCs rather than human subjects. Gender of participants was not collected because it was not applicable.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Not collected</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent of Patients Receiving GI Consult for FOBT+ Results</title>
        <description>Percent of patients receiving GI consult within 30, 90, and 180 days of FOBT+ results</description>
        <time_frame>6 months</time_frame>
        <population>Sites that completed the intervention and post-intervention data collection were included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Electronic Consult System 1st Site (1a)</title>
            <description>A new consult system designed to automatically send a gastroenterology consult request for patients with positive fecal occult blood testing (FOBT+) results</description>
          </group>
          <group group_id="O2">
            <title>Electronic Consult System 2nd Site (2a)</title>
            <description>A new consult system designed to automatically send a gastroenterology consult request for patients with FOBT+ results</description>
          </group>
          <group group_id="O3">
            <title>Usual Care 1st Site (1b)</title>
            <description>The usual and customary procedures for addressing FOBT+ results: primary care physicians continued to be responsible for follow up of FOBT+ results.</description>
          </group>
          <group group_id="O4">
            <title>Usual Care 2nd Site (2b)</title>
            <description>The usual and customary procedures for addressing FOBT+ results: primary care physicians continued to be responsible for follow up of FOBT+ results.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Patients Receiving GI Consult for FOBT+ Results</title>
          <description>Percent of patients receiving GI consult within 30, 90, and 180 days of FOBT+ results</description>
          <population>Sites that completed the intervention and post-intervention data collection were included in the analysis</population>
          <units>percent patients receiving GI consult</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>pre intervention--consult within 30 days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="47"/>
                    <measurement group_id="O3" value="64"/>
                    <measurement group_id="O4" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post intervention--consult within 30 days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68"/>
                    <measurement group_id="O2" value="80"/>
                    <measurement group_id="O3" value="63"/>
                    <measurement group_id="O4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>pre intervention--consult within 90 days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="50"/>
                    <measurement group_id="O3" value="70"/>
                    <measurement group_id="O4" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post intervention--consult within 90 days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="82"/>
                    <measurement group_id="O3" value="69"/>
                    <measurement group_id="O4" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>pre intervention--consult within 180 days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="55"/>
                    <measurement group_id="O3" value="71"/>
                    <measurement group_id="O4" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post intervention--consult within 180 days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                    <measurement group_id="O2" value="86"/>
                    <measurement group_id="O3" value="72"/>
                    <measurement group_id="O4" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percent of Patients Receiving GI Consult Plus Anatomic Workup for FOBT+ Results</title>
        <description>Percent of patients receiving GI consult plus anatomic workup within 30, 90, and 180 days of FOBT+ results</description>
        <time_frame>6 months</time_frame>
        <population>Sites that completed the intervention and post-intervention data collection were included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Electronic Consult System 1st Site (1a)</title>
            <description>A new consult system designed to automatically send a gastroenterology consult request for patients with positive fecal occult blood testing (FOBT+) results</description>
          </group>
          <group group_id="O2">
            <title>Electronic Consult System 2nd Site (2a)</title>
            <description>A new consult system designed to automatically send a gastroenterology consult request for patients with FOBT+ results</description>
          </group>
          <group group_id="O3">
            <title>Usual Care 1st Site (1b)</title>
            <description>The usual and customary procedures for addressing FOBT+ results: primary care physicians continued to be responsible for follow up of FOBT+ results.</description>
          </group>
          <group group_id="O4">
            <title>Usual Care 2nd Site (2b)</title>
            <description>The usual and customary procedures for addressing FOBT+ results: primary care physicians continued to be responsible for follow up of FOBT+ results.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Patients Receiving GI Consult Plus Anatomic Workup for FOBT+ Results</title>
          <description>Percent of patients receiving GI consult plus anatomic workup within 30, 90, and 180 days of FOBT+ results</description>
          <population>Sites that completed the intervention and post-intervention data collection were included in the analysis</population>
          <units>percent patients with GI consult+workup</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>pre intervention--consult+workup in 30 days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post intervention--consult+workup in 30 days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>pre intervention--consult+workup in 90 days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="44"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post intervention--consult+workup in 90 days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="50"/>
                    <measurement group_id="O4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>pre intervention--consult+workup in 180days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="48"/>
                    <measurement group_id="O4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post intervention--consult+workup in 180days FOBT+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="42"/>
                    <measurement group_id="O3" value="54"/>
                    <measurement group_id="O4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Adverse events were not formally monitored because participants were VAMCs, not human subjects. The study involved extracting information from individual medical records at each VAMC. There were no reported problems involving this use of records.</desc>
      <group_list>
        <group group_id="E1">
          <title>Electronic Consult System</title>
          <description>A new consult system designed to automatically send a gastroenterology consult request for patients with positive fecal occult blood testing (FOBT+) results</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>The usual and customary procedures for addressing FOBT+ results: primary care physicians continued to be responsible for follow up of FOBT+ results.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Half of the sites randomized did not complete the study. GI referral rates should have been nearly 100%, yet were not. Because of programming limitations, we were unable to evaluate the type of diagnostic interventions the patients received.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Linda Humphrey</name_or_title>
      <organization>VAHSRD</organization>
      <phone>503-220-8262 ext 57176</phone>
      <email>linda.humphrey@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

